John Crumpler


Chairman of the Board of Directors

John Crumpler

John Crumpler co-founded Hatteras Venture Partners in 2000 after a successful career as a technology entrepreneur. At Hatteras, John is responsible for the firm’s investments in healthcare and life science information technology, and overall fund operations. He was founder and CEO of E-Comm, Inc., a software development and services firm specializing in remote and mobile computing that was acquired by XcelleNet. John ran the services division of XcelleNet until the company was acquired by Sterling Commerce.

John served on the boards of Synthematix and Clinverse, and currently serves on the boards of Medfusion, Jumo Health, Wildflower Health, Bivarus and Clinipace Worldwide. At Clinipace John has helped lead the transformation of Clinipace from a pure software company to a full-service digital CRO. He holds an A.B. from Harvard University.

Community and Board Engagements:

Throughout his career John has been active in government and public policy at the state and federal levels. A recipient of the Lyndhurst Prize, John served on the N. C. Economic Development Board, the state’s Clean Water Management Trust Fund board of directors, and as a trustee of the University of North Carolina School of the Arts. He currently serves on the board of the Council for Entrepreneurial Development and as a director of SouthLight Healthcare.

Kenneth B. Lee, Jr.


Secretary of the Board of Directors

Kenneth B. Lee, Jr.

Kenneth B. Lee, Jr. is involved in deal sourcing, investment decisions, board work, and exit strategies as a general partner of HVP III. He is also a general partner for HVP II, where he has played an important role in deal sourcing, syndication and management recruitment, and valuation of Hatteras investments. Ken is the former co-head of International Life Sciences for Ernst & Young, where he established a career over 29 years advising biotechnology and pharmaceutical companies throughout the world

He got his start in biotech as part of the first audit team of Genentech in 1976. As co-founder and manager of the firm’s national life sciences practice from his location in the San Francisco Bay Area, he advised numerous high profile life science companies with their initial public offerings, mergers and acquisitions, and strategic financings. Among others, these included: Affymax, Affymetrix, Applied ImmuneSciences, Chiron, Circadian, Genentech, Heartport, Systemix, ALZA, and Collagen.

Ken served on the Board of Directors of Clinverse and is Chairman of the Board of Clinipace. He graduated with a BA from Lenoir-Rhyne College and has an MBA from the University of North Carolina at Chapel Hill.

Community and Board Engagements:

Ken is a nationally-recognized financial matters expert and serves on the boards of Biocryst and Aralez, two publicly held biotech companies. He formerly served on the boards of Abgenix, CV Therapeutics, Inspire Pharmaceuticals (where he served as Chairman), Maxygen and OSI Pharmaceuticals. Ken also serves on the Board of the North Carolina Medical Foundation.

David W. Jessen, CPA


Treasurer of the Board of Directors

David W. Jessen, CPA

David Jessen is a retired partner from the international accounting firm Ernst & Young. Over the course of his 35-year career, he served as Director of Tax, Carolinas’ and Southeast Region Director of Entrepreneurial Services, and Office Managing Partner. David provided tax and financial consulting services to public and private corporations in pharmaceutical, biotech, manufacturing, telecom, real estate, and other industries. His technical specialties included equity compensation, FAS 109, mergers and acquisitions, due diligence, business formation, and international tax issues.

David is currently the Executive-in-Residence at the University of North Carolina-Wilmington, Cameron School of Business, having joined its faculty in the Department of Accountancy and Business Law in August 2008.

David is a licensed CPA who received his undergraduate degree from the University of New Mexico. He also completed the Ernst & Young Executive Development Program conducted by Harvard University.

Community and Board Engagements:

David has served on several community boards, many as treasurer, including: Wake Med Health & Hospitals, Inc., Wake Med Foundation, Inc., North Carolina Museum of Art Foundation, Food Bank of North Carolina, Council for Entrepreneurial Development, North Carolina Society to Prevent Blindness, and others.